Dennis Roberts
**** ***** ** ** . *******, WA ***12 . acceck@r.postjobfree.com . 206-
QA / QC Executive
QUALITY ASSURANCE / AUDITS / QUALITY CONTROL
INSPECTIONS / PERFORMANCE ANALYSIS / ASSESSMENT
SEASONED AND HIGHLY FOCUSED QUALITY ASSURANCE / CONTROL LEADER WITH PROVEN
PROFICIENCY GAINED THROUGH 20+ YEARS' SUCCESS GUIDING TEAMS TO IDENTIFY AND
REMEDY AREAS REQUIRING STRICT, LASTING, AND HIGH-IMPACT TURN-AROUND
INITIATIVES. SOLID HISTORY OF TRAINING AND MENTORING TEAMS TO MEET GMP AND
GCP REGULATIONS AND FOR REGULATORY SUBMISSIONS. POSSESS PHARMACEUTICAL AND
BIOTECHNOLOGY EXPERTISE IN API, STERILE DRUG PRODUCTS, AND SOLID ORAL
MANUFACTURING.
SOLID HISTORY OF OVERSEEING COMPREHENSIVE OPERATIONS WHILE DEVELOPING AND
DISSEMINATING REGULATORY DOCUMENTATION AND REPORTS. SKILLFULLY ALIGN
PROCESSES WITH INDUSTRY STANDARDS TO ADDRESS AUDIT FINDINGS. COORDINATE
WITH INTERNAL / EXTERNAL TEAMS AND VENDORS AS WELL AS GLOBAL PROFESSIONALS
TO MEET ALL GOALS.
AREAS OF EXPERTISE:
QUALITY/MANUFACTURING Manufacturing Project Management
TECHNOLOGY
Research and Analysis / Audits Quality Standards Assessment
Product Formulation / Health Authority (FDA, EMA)
Development Inspections
Regulatory and Industry Internal Systems and Controls
Compliance Operations Analysis / Process
Team Training & Mentoring Validation
Professional Experience
CELL THERAPEUTICS - SEATTLE, WA
Promoted through multiple positions of increasing scope and responsibility
to hold executive-level role overseeing product quality management
endeavors for top-performing pharmaceutical development company.
Vice President, Quality (11/2009 to 3/2013)
Created and implemented processes to align pharmaceutical manufacturing
operations with industry and legal regulations to include executing SOPs
and Quality Agreements in manufacturing, regulatory submissions, and vendor
selection / relations. Oversaw Quality Assurance for GMP compliance of
contractors (API, finished dosage), teams, and internal systems. Managed
Good Clinical Practice processes for investigators and CROs. Directed and
supervised teams, led team meetings, and served as key FDA representative
for company. Handled stakeholder / partner relationships. Identified
performance gaps and created SOPs to remedy inefficiencies and streamline
processes. Wrote and approved manufacturing reports; verified data and
conclusions for deviation and OOS investigations, CAPA, and change control
measures. Selected Contributions:
- Reduced labor costs related to managing training records by sourcing
and implementing a web-based training program.
- Bridged efficiency gaps through sourcing external resources in
training for GMP, GCP, risk management, and additional internal areas
requiring performance turn-around.
- Minimized negatively cited observations and optimized site corrections
by thoroughly preparing for FDA PAI inspections; led internal teams of
regulatory and SMEs to meet strict GCP requirements.
- Adeptly resolved critical FDA inspector identified analytical testing
issue at contract manufacturing site; site successfully passed
inspections following remedy measures.
- Administered ~$5M departmental budget while overseeing teams to meet
continued performance and compliance efforts during a revenue downturn
and budget cuts to <$2M.
Cell Therapeutics - Seattle, WA
Senior Director / Director, Quality Operations (6/2006 to 11/2009)
Supervised and managed team of 4 Quality Control Specialists and 1 Manager,
as well as 2 Document Control Specialists while handling complete
management functions for the Quality Group to include QC operations and
document control. Created and managed budgets. Oversaw external CMO and
contract testing lab operations. Handled processes for product releases
including methods and testing, stability program, and reporting. Managed
batch records, change control, SOPs, and specifications to align with
document control processes. Oversaw vendor teams. Participated in and led
CMC teams; contributed to regulatory filings; contributed to submission
process (IND, NDA, MAA). Selected Contributions:
- Optimized global team relationships through developing strong vendor
and staff partnerships.
- Served as leader during MAA negotiations with Dutch and German
Rapporteurs for Paclitaxel Poliglumex; served as the CMC expert.
Cell Therapeutics - Seattle, WA
CMC Contractor (6/2005 to 6/2006)
Chosen for contract role overseeing multiple QC endeavors; retained for
permanent role following contract closure. Managed transition of CMC
information on Trisenox (arsenic trioxide injection) during post-sale
stages to new company. Handled all QC testing of Paclitaxel Poliglumex
product (method change control, stability testing, specification
development). Maintained international relations with global managers,
scientists, and teams. Aligned all processes to meet deadlines and control
cost.
Cell Therapeutics - Seattle, WA
Director, Quality Control (7/2001 to 6/2005)
Collaborated on development and implementation of multiple quality control
measurements and improvement processes to meet industry and legal
regulations. Managed and led team completing project to validate terminal
heat sterilization of commercial product, Trisenox. Served as CMC expert
for coordinating with stakeholders involved with MAA for Paclitaxel
Poliglumex; improved product testing through selecting and validating
select QC test facility. Chosen to remain onboard during company's merger
and acquisition.
Additional Experience
Director, Product Development ( Akorn, Inc., Decatur, IL
- Managed to contract development leading to up to17% increase in
profits; built GMP compliant lab from ground-up to realize strong
profit center standing.
- Set record for speedy approval of oncology drug; delivered NDA
supportive documents for client, CTI, for Trisenox; hit goal 3 months
ahead of schedule.
Plant Manager ( Pegasus Labs, Pensacola, FL
- Redesigned and launched new manufacturing process for gelled calcium
supplement which resulted in a tripling of product output and improved
product quality and consistency.
- Reduced waste and improved materials accounting through overhauling
inventory system.
Analytical Chemist ( Steris Laboratories, Phoenix, AZ
- Increased robustness of methods through employing thorough literature
research review methods.
- Enhanced knowledge-sharing by improving efficiency of lab notebook
maintenance.
- Identified and corrected sampling method errors for testing Metered
Dose Inhalers.
Education and Credentials
BACHELOR OF SCIENCE IN CHEMISTRY ( WASHINGTON STATE UNIVERSITY - PULLMAN,
WA
Member, Parenteral Drug Association, 9/'01 to 10/'12
Technologies: Microsoft Office Suite (Word, Excel, PowerPoint, Outlook),
Livelink, Eduneering, Agilent Chemstation, Stability management database,
Novell network, and NovaTek stability